Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Levalbuterol Tartrate HFA in Pediatric Acute Bronchospasm
NCT02150499Phase 3Terminated
- Sponsor
- Sumitomo Pharma America
- Start
- Jul 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levalbuterol in asthma, sponsored by Sumitomo Pharma America. Started Jul 2014; status: terminated.
02
Drugs
levalbuterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02150499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02150499.